PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Faculty of Pharmaceutical Sciences, Shoolini University of Biotechnology and Management Sciences, Solan, India.\', \'Department of Biological Sciences, Institute of Advanced Research, Gandhinagar, India.\', \'Department of Microbiology & Biotechnology, University School of Sciences, Gujarat University, Ahmedabad, India.\', \'Department of Biotechnology, Yeshiva University, New York, NY, USA.\', \'Department of Pharmacology, Chitkara University, Punjab, India.\', \'Department of Pharmacology, Govt. College of Pharmacy, Rohru, India.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1080/03639045.2021.1934857
?:doi
?:hasPublicationType
?:journal
  • Drug development and industrial pharmacy
is ?:pmid of
?:pmid
?:pmid
  • 34038246
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.519
?:rankingScore_hIndex
  • 73
is ?:relation_isRelatedTo_publication of
?:title
  • Reckoning γ-Glutamyl-S-allylcysteine as a potential main protease (mpro) inhibitor of novel SARS-CoV-2 virus identified using docking and molecular dynamics simulation.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all